ibandronic acid has been researched along with Milk-Alkali Syndrome in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (37.50) | 18.2507 |
| 2000's | 19 (59.38) | 29.6817 |
| 2010's | 1 (3.13) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachmann, R; Bisping, M; Born, AR; Cortesi, R; Glatt, M; Green, JR; Guiglia, G; Jaeggi, KA; Jeker, H; Klein, R; Müller, K; Ramseier, U; Schmid, J; Schreiber, G; Seltenmeyer, Y; Widler, L | 1 |
| Ogrin, C | 1 |
| Artunc, F; Friedrich, B; Georges, CG; Gröne, E; Guthoff, M; Müssig, K; Risler, T; Teichmann, R; Wehrmann, M | 1 |
| Baraniskin, A; Schmiegel, W; Schroers, R | 1 |
| Berenson, JR | 1 |
| Bergström, B; Pecherstorfer, M; Rizzoli, R; Steinhauer, EU; Wetterwald, M | 1 |
| Berenson, J; Hirschberg, R | 1 |
| Diel, IJ; Pecherstorfer, M | 1 |
| Heidenreich, A; Ohlmann, CH | 1 |
| Bian, SG; Jiang, ZF; Li, LQ; Song, ST; Wang, T; Wang, YJ; Zhu, J | 1 |
| Balla, J | 1 |
| Lugassy, G | 1 |
| Bergner, R; Bruckner, D; Henrich, DM; Hoffmann, M; Uppenkamp, M | 1 |
| Guay, DR | 1 |
| Daphnis, E; Karamitopoulou, E; Karkavitsas, N; Katsipi, I; Kyriazis, J; Stratigis, S; Stylianou, K | 1 |
| Bergner, R; Henrich, D; Hoffmann, M; Uppenkamp, M | 1 |
| Baumgartner, G; Blind, E; Pecherstorfer, M; Raue, F; Schilling, T; Ziegler, R; Zimmer-Roth, I | 1 |
| Clemens, MR; Ghielmini, M; Jaeger, P; Krahl, D; Manegold, C; Scharla, SH; Schöter, KH; Thiébaud, D; Wüster, C | 1 |
| Blind, E; Meinel, T; Raue, F; Wüster, C; Ziegler, R | 1 |
| Body, JJ; Clemens, MR; Degardin, M; Herrmann, Z; Huss, HJ; Manegold, C; Pecherstorfer, M; Steinhauer, EU; Thiébaud, D; Thürlimann, B; Tubiana-Hulin, M; van Eijkeren, M | 1 |
| Irzyniec, T; Kokot, F; Wiecek, A; Wnuk, RS | 1 |
| Coleman, R; Vinholes, J | 1 |
| Body, JJ; Dumon, JC; Oleffe, V | 1 |
| Body, JJ; Hagberg, H; Herrmann, Z; Huss, HJ; Lichinitser, MR; Ralston, SH; Rizzoll, R; Steinhauer, EU; Thiébaud, D; Thürlimann, B; Tubiana-Hulin, M; Walls, J | 1 |
| Burckhardt, P | 1 |
| Bartl, R; Body, JJ; Burckhardt, P; Delmas, PD; Diel, IJ; Fleisch, H; Kanis, JA; Kyle, RA; Mundy, GR; Paterson, AH; Rubens, RD | 1 |
| Balfour, JA; Dooley, M | 1 |
| Body, JJ; Bundred, N; Clemens, MR; Degardin, M; Eghbali, H; Herrmann, Z; Huss, HJ; Manegold, C; Pecherstorfer, M; Rizzoli, R; Rückert, F; Steinhauer, EU; Thiébaud, D; Thürlimann, B; Tubiana-Hulin, M | 1 |
| Body, JJ | 1 |
| Alsina, M; Anderson, JL; Craig, F; Cruz, JC; Dallas, M; Roodman, GD; Yoneda, T | 1 |
| Boewer, C; Delmas, PD; Euller-Ziegler, L; Facon, T; Fiere, D; Fontana, A; Herrmann, Z; Hrubisko, M; Lichinitser, MR; Menssen, HD; Sakalová, A; Singer, CR; Thiel, E; Wetterwald, M | 1 |
11 review(s) available for ibandronic acid and Milk-Alkali Syndrome
| Article | Year |
|---|---|
[Emergencies in hematology and oncology].
Topics: Acute Kidney Injury; Biopsy; Bone Density Conservation Agents; Carcinoma, Bronchogenic; Diphosphonates; Emergencies; Fatal Outcome; Fluid Therapy; Hemodiafiltration; Humans; Hypercalcemia; Ibandronic Acid; Lung; Lung Neoplasms; Male; Middle Aged; Palliative Care; Paraneoplastic Syndromes; Parathyroid Hormone; Parathyroid Hormone-Related Protein | 2009 |
Treatment of hypercalcemia of malignancy with bisphosphonates.
Topics: Bone Resorption; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Ibandronic Acid; Imidazoles; Neoplasms; Pamidronate; Zoledronic Acid | 2002 |
Safety and convenience of a 15-minute infusion of zoledronic acid.
Topics: Antineoplastic Agents; Bone Neoplasms; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Ibandronic Acid; Imidazoles; Infusions, Intravenous; Pamidronate; Time Factors; Zoledronic Acid | 2004 |
Rapid administration of ibandronate does not affect renal functioning: evidence from clinical studies in metastatic bone disease and hypercalcaemia of malignancy.
Topics: Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Hypercalcemia; Ibandronic Acid; Infusions, Intravenous; Injections, Intravenous; Kidney Diseases | 2004 |
Ibandronate: its pharmacology and clinical efficacy in the management of tumor-induced hypercalcemia and metastatic bone disease.
Topics: Administration, Oral; Bone Density Conservation Agents; Bone Neoplasms; Bone Resorption; Diphosphonates; Humans; Hypercalcemia; Ibandronic Acid; Infusions, Intravenous; Neoplasms; Osteoporosis; Product Surveillance, Postmarketing; Risk Factors | 2004 |
Ibandronate, an experimental intravenous bisphosphonate for osteoporosis, bone metastases, and hypercalcemia of malignancy.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Drug Interactions; Humans; Hypercalcemia; Ibandronic Acid; Injections, Intravenous; Neoplasms; Osteoporosis | 2006 |
Tumor-induced hypercalcemia in a patient with extensive soft tissue sarcoma: effects of bisphosphonate therapy and surgery.
Topics: Adult; Bone Resorption; Chemotherapy, Adjuvant; Diphosphonates; Female; Humans; Hypercalcemia; Ibandronic Acid; Leg; Sarcoma, Synovial; Time Factors | 1996 |
Ibandronate in oncology.
Topics: Bone Density; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Calcium; Diphosphonates; Female; Humans; Hypercalcemia; Ibandronic Acid; Neoplasms; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic | 1997 |
Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
Topics: Analgesics, Non-Narcotic; Bone and Bones; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Ibandronic Acid; Multiple Myeloma; Pain; Pamidronate | 1998 |
Ibandronate.
Topics: Animals; Bone Density; Bone Neoplasms; Bone Resorption; Diphosphonates; Female; Humans; Hypercalcemia; Ibandronic Acid; Male; Neoplasms; Osteitis Deformans; Osteoporosis, Postmenopausal | 1999 |
Current and future directions in medical therapy: hypercalcemia.
Topics: Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Ibandronic Acid; Imidazoles; Neoplasms; Pamidronate; Zoledronic Acid | 2000 |
7 trial(s) available for ibandronic acid and Milk-Alkali Syndrome
| Article | Year |
|---|---|
Efficacy and safety of ibandronate in the treatment of hypercalcemia of malignancy: a randomized multicentric comparison to pamidronate.
Topics: Administration, Oral; Aged; Anti-Inflammatory Agents; Bone Resorption; Diphosphonates; Female; Humans; Hypercalcemia; Ibandronic Acid; Male; Middle Aged; Neoplasms; Pamidronate; Treatment Outcome | 2003 |
[Clinical trial on ibandronate in patients with tumor-associated hypercalcemia].
Topics: Bone Neoplasms; Breast Neoplasms; Calcium; Diphosphonates; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fever; Humans; Hypercalcemia; Ibandronic Acid; Lung Neoplasms; Male; Middle Aged; Multiple Myeloma; Phosphorus; Pruritus | 2004 |
Methylpentylaminopropylidenebisphosphonate (BM 21.0955): a new potent and safe bisphosphonate for the treatment of cancer-associated hypercalcemia.
Topics: Aged; Bone Resorption; Calcium; Diphosphonates; Female; Humans; Hypercalcemia; Ibandronic Acid; Injections, Intravenous; Male; Middle Aged; Neoplasms | 1993 |
Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy.
Topics: Adult; Aged; Aged, 80 and over; Bone Resorption; Calcium; Diphosphonates; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fever; Humans; Hypercalcemia; Ibandronic Acid; Male; Middle Aged; Nausea; Neoplasms; Recurrence; Regression Analysis; Thrombocytopenia; Treatment Outcome | 1996 |
Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia.
Topics: Bone Resorption; Diphosphonates; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypercalcemia; Ibandronic Acid; Infusions, Intravenous; Male; Middle Aged | 1997 |
Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy.
Topics: Absorption; Calcium; Cohort Studies; Diphosphonates; Female; Humans; Hypercalcemia; Ibandronic Acid; Kidney Tubules; Male; Middle Aged; Neoplasms; Parathyroid Hormone-Related Protein; Proteins; Recurrence; Syndrome; Treatment Outcome | 1999 |
Effects of long-term intravenous ibandronate therapy on skeletal-related events, survival, and bone resorption markers in patients with advanced multiple myeloma.
Topics: Bone Resorption; Chi-Square Distribution; Diphosphonates; Double-Blind Method; Female; Fractures, Bone; Humans; Hypercalcemia; Ibandronic Acid; Injections, Intravenous; Male; Middle Aged; Multiple Myeloma; Pain; Spinal Cord Compression; Survival Analysis; Treatment Outcome | 2002 |
14 other study(ies) available for ibandronic acid and Milk-Alkali Syndrome
| Article | Year |
|---|---|
Highly potent geminal bisphosphonates. From pamidronate disodium (Aredia) to zoledronic acid (Zometa).
Topics: Animals; Bone Resorption; Calcitriol; Diphosphonates; Hypercalcemia; Imidazoles; In Vitro Techniques; Kidney; Mice; Pamidronate; Parathyroidectomy; Rats; Skull; Structure-Activity Relationship; Thyroidectomy; Zoledronic Acid | 2002 |
Evaluation of parathyroid levels and bone densitometry after cinacalcet treatment in severe primary hyperparathyroidism.
Topics: Alkaline Phosphatase; Bone Density; Calcium; Cinacalcet; Diphosphonates; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Ibandronic Acid; Naphthalenes; Osteoporosis; Parathyroid Hormone; Phosphates; Vitamin D | 2013 |
[Hypercalcaemic crisis and acute renal failure due to primary hyperparathyroidism].
Topics: Acute Kidney Injury; Adenoma; Diphosphonates; Emergencies; Female; Fluid Therapy; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Ibandronic Acid; Middle Aged; Parathyroid Neoplasms; Renal Dialysis | 2008 |
[Bone metastases in breast carcinoma. Bisphosphonate protects from complications].
Topics: Administration, Oral; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Clinical Trials as Topic; Diphosphonates; Female; Humans; Hypercalcemia; Ibandronic Acid; Time Factors | 2004 |
The issue of renal safety of zoledronic acid from a nephrologist's point of view.
Topics: Antineoplastic Agents; Bone Neoplasms; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Ibandronic Acid; Imidazoles; Infusions, Intravenous; Pamidronate; Time Factors; Zoledronic Acid | 2005 |
"Safety and convenience of a 15-minute infusion of zoledronic acid": not so safe.
Topics: Antineoplastic Agents; Bone Neoplasms; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Ibandronic Acid; Imidazoles; Infusions, Intravenous; Pamidronate; Time Factors; Zoledronic Acid | 2005 |
[Therapy of hypercalcemia with ibandronate in case of acute renal failure].
Topics: Acute Kidney Injury; Adenoma; Aged; Bone Density Conservation Agents; Calcium; Creatinine; Diagnosis, Differential; Diphosphonates; Female; Humans; Hypercalcemia; Hyperparathyroidism; Ibandronic Acid; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Recurrence | 2006 |
Parathyromatosis and the challenge of treatment.
Topics: Adult; Bone Density Conservation Agents; Diphosphonates; Disease Progression; Ergocalciferols; Female; Humans; Hypercalcemia; Hyperparathyroidism; Ibandronic Acid; Kidney Failure, Chronic; Renal Dialysis; Reoperation | 2006 |
Ibandronate for the treatment of hypercalcemia or nephrocalcinosis in patients with multiple myeloma and acute renal failure: Case reports.
Topics: Acute Kidney Injury; Aged; Calcium; Creatinine; Diphosphonates; Fatal Outcome; Female; Humans; Hypercalcemia; Ibandronic Acid; Injections, Intravenous; Male; Middle Aged; Multiple Myeloma; Nephrocalcinosis | 2006 |
Parathyroid hormone-related protein and life expectancy in hypercalcemic cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Diphosphonates; Female; Humans; Hypercalcemia; Ibandronic Acid; Life Expectancy; Male; Middle Aged; Neoplasms; Pamidronate; Parathyroid Hormone-Related Protein; Proteins; Survival Rate | 1994 |
Levels of parathyroid hormone-related protein (PTHrP) in hypercalcemia of malignancy are not lowered by treatment with the bisphosphonate BM 21.0955.
Topics: Adult; Aged; Calcium; Diphosphonates; Female; Humans; Hypercalcemia; Ibandronic Acid; Male; Middle Aged; Neoplasms; Parathyroid Hormone-Related Protein; Proteins | 1993 |
[Use of third generation bisphosphonates in treatment of neoplastic hypercalcemia].
Topics: Adult; Aged; Calcium; Creatinine; Diphosphonates; Female; Humans; Hypercalcemia; Ibandronic Acid; Male; Middle Aged; Neoplasms | 1995 |
The management of bone metastases.
Topics: Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Diphosphonates; Female; Humans; Hypercalcemia; Ibandronic Acid; Middle Aged; Pain | 1995 |
Ibandronate decreases bone disease development and osteoclast stimulatory activity in an in vivo model of human myeloma.
Topics: Animals; Bone Diseases; Bone Marrow Cells; Cell Division; Cell Survival; Diphosphonates; Disease Models, Animal; Humans; Hypercalcemia; Ibandronic Acid; Immunoglobulin G; Immunoglobulin kappa-Chains; Leukemia, Plasma Cell; Mice; Mice, SCID; Multiple Myeloma; Neoplasm Transplantation; Osteoclasts; Osteolysis; Paraplegia; Tumor Cells, Cultured | 2001 |